HomeNewscoronavirusIndia's fight against COVID sets positive global example: Gates Foundation's Mark Suzman

India's fight against COVID sets positive global example: Gates Foundation's Mark Suzman

Mark Suzman emphasised that in the midst of the pandemic, India has appeared as a 'bright spot'. He cited various steps taken by India such as vaccination and nutrition campaigns and sanitation campaigns in helping India conduct inoculation at a massive scale.

January 17, 2023 / 15:56 IST
Story continues below Advertisement
Mark Suzman, CEO of Bill and Melinda Gates Foundation
Mark Suzman, CEO of Bill and Melinda Gates Foundation

Mark Suzman, CEO of Bill and Melinda Gates Foundation said India's fight against the COVID crisis has set a positive global example. He also said that it can be a model for others on how India addressed the manufacturing and distribution of vaccines at such a scale.

“We were proud to be able to work with the Indian government and with partners like the Serum Institute of India, to help manufacture some of the vaccines and to help with some of the primary health care facilities to help with distribution and in some of the states like Uttar Pradesh and Bihar where we work closely, but it really is a model both because of the direct COVID response, but also because the infrastructure that's been put in place has lots of positive effects by other forms of healthcare,” Suzman told ANI.

Story continues below Advertisement

The latest data on inoculation by the Ministry of Health and Family Welfare says that over 2.2 billion doses of the vaccine have been administered so far.

Elaborating on the challenges faced by the world during and after the pandemic, Suzman emphasised that a big part of the world's economies are likely to be in recession.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show